Abstract: An expert group representing a wide range of stakeholders and disciplines was convened by WHO and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in June, 2017. The group generated a set of practical recommendations for patient engagement in drug development, clinical research, and regulatory decision making. These are discussed in this letter to the journal.
External link: The following links will take you to information on this entry on an external website. INVOLVE is not responsible for the content or the reliability of the external websites. Click here
Related entry: none currently available
Categories: health nature and extent of public involvement in research reflecting on public involvement in research editorial
Date Entered: 2019/04/08
Date Edited: 2019/04/08